Guo WJ - Search Results

1

Randomized phase II study of TX followed by XELOX versus the reverse sequence for chemo-naive patients with metastatic gastric cancer.

Zhao XY, Liu X, Li WH, Qiu LX, Huang MZ, Wang CC, Chen ZY, Zhang W, Feng WJ, Guo WJ, Zhu X. Zhao XY, et al. Among authors: guo wj. Front Oncol. 2022 Oct 26;12:911160. doi: 10.3389/fonc.2022.911160. eCollection 2022. Front Oncol. 2022. PMID: 36387112 Free PMC article.

2

Octreotide augments the effects of hepatic arterial occlusion in treating a rat liver tumor model.

Guo WJ, Zhuang JY, Bai YR, Li J, Cheng YF, Shen Z, Li WH, Zhang WZ, Cai R. Guo WJ, et al. Hepatogastroenterology. 2003 Mar-Apr;50(50):349-53. Hepatogastroenterology. 2003. PMID: 12749218

3

Oncogenic role of the chromobox protein CBX7 in gastric cancer.

Zhang XW, Zhang L, Qin W, Yao XH, Zheng LZ, Liu X, Li J, Guo WJ. Zhang XW, et al. Among authors: guo wj. J Exp Clin Cancer Res. 2010 Aug 19;29(1):114. doi: 10.1186/1756-9966-29-114. J Exp Clin Cancer Res. 2010. PMID: 20723236 Free PMC article.

4

Cetuximab enhances the activities of irinotecan on gastric cancer cell lines through downregulating the EGFR pathway upregulated by irinotecan.

Liu X, Guo WJ, Zhang XW, Cai X, Tian S, Li J. Liu X, et al. Among authors: guo wj. Cancer Chemother Pharmacol. 2011 Oct;68(4):871-8. doi: 10.1007/s00280-011-1559-2. Epub 2011 Feb 1. Cancer Chemother Pharmacol. 2011. PMID: 21286718

5

GSTM1 null allele is a risk factor for gastric cancer development in Asians.

Qiu LX, Wang K, Lv FF, Chen ZY, Liu X, Zheng CL, Li WH, Zhu XD, Guo WJ, Li J. Qiu LX, et al. Among authors: guo wj. Cytokine. 2011 Jul;55(1):122-5. doi: 10.1016/j.cyto.2011.03.004. Epub 2011 Apr 6. Cytokine. 2011. PMID: 21474334

6

18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.

Zhou M, Wang C, Hu S, Zhang Y, Yao Z, Li J, Guo W, Zhang Y. Zhou M, et al. Nucl Med Commun. 2013 Jul;34(7):694-700. doi: 10.1097/MNM.0b013e328361663a. Nucl Med Commun. 2013. PMID: 23604223

7

Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial.

Li J, Qin S, Xu J, Guo W, Xiong J, Bai Y, Sun G, Yang Y, Wang L, Xu N, Cheng Y, Wang Z, Zheng L, Tao M, Zhu X, Ji D, Liu X, Yu H. Li J, et al. J Clin Oncol. 2013 Sep 10;31(26):3219-25. doi: 10.1200/JCO.2013.48.8585. Epub 2013 Aug 5. J Clin Oncol. 2013. PMID: 23918952 Clinical Trial.

8

COX-2-765G>C polymorphism increases the risk of cancer: a meta-analysis.

Wang XF, Huang MZ, Zhang XW, Hua RX, Guo WJ. Wang XF, et al. Among authors: guo wj. PLoS One. 2013 Sep 4;8(9):e73213. doi: 10.1371/journal.pone.0073213. eCollection 2013. PLoS One. 2013. PMID: 24023834 Free PMC article.

9

Phase I and pharmacokinetic study of polymeric micelle‑formulated paclitaxel in adult Chinese patients with advanced solid tumors.

Lv F, Cao J, Zhang J, Qian J, Peng W, Sun S, Li W, Zhang W, Guo W, Li J. Lv F, et al. Cancer Chemother Pharmacol. 2014 Jun;73(6):1173-9. doi: 10.1007/s00280-014-2452-6. Cancer Chemother Pharmacol. 2014. PMID: 24658629 Clinical Trial.

10

Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors.

Zhu X, Zhao X, Peng W, Sun S, Cao J, Ji D, Liu X, Wang C, Huang M, Yu H, Guo W, Li J, Yin J. Zhu X, et al. J Cancer Res Clin Oncol. 2015 Jan;141(1):109-18. doi: 10.1007/s00432-014-1754-8. Epub 2014 Jul 18. J Cancer Res Clin Oncol. 2015. PMID: 25035248 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

302 results

Search Page